Amgen Inc.

Amgen Inc. is a leading biotechnology company that specializes in the discovery, development, and commercialization of innovative human therapeutics. With its headquarters in Thousand Oaks, California, Amgen has a prominent role in the life sciences sector, focusing on advancing medicines for serious illnesses. The company's primary purpose is to harness the power of cellular and molecular biology to provide treatments for grievous conditions such as cancer, kidney disease, rheumatoid arthritis, and bone disease. Noteworthy for its pioneering work in biotechnology, Amgen develops a wide range of biopharmaceuticals designed to enhance patient care and outcomes. The company has a robust pipeline of new medicines and has contributed significantly to the advancement of biological therapies. Its market significance is underscored by its position as one of the largest independent biotechnology firms in the world. Amgen's products are widely utilized across healthcare settings, and its innovations continue to have a profound impact on the pharmaceutical industry, shaping the future of therapeutic interventions globally.